Cargando…
Metabolism addiction in pancreatic cancer
Pancreatic ductal adenocarcinoma, an aggressively invasive, treatment-resistant malignancy and the fourth leading cause of cancer deaths in the United States, is usually detectable only when already inevitably fatal. Despite advances in genetic screening, mapping and molecular characterization, its...
Autores principales: | Blum, R, Kloog, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944253/ https://www.ncbi.nlm.nih.gov/pubmed/24556680 http://dx.doi.org/10.1038/cddis.2014.38 |
Ejemplares similares
-
FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in
mice
por: Goldberg, L, et al.
Publicado: (2012) -
Metabolic features of cancer cells in NRF2 addiction status
por: Okazaki, Keito, et al.
Publicado: (2020) -
The metabolic addiction of cancer stem cells
por: Sahoo, Om Saswat, et al.
Publicado: (2022) -
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016) -
Glucose Metabolism in Pancreatic Cancer
por: Yan, Liang, et al.
Publicado: (2019)